

# **Cognitive Liberty and the Charter: A Case for Reforming Canada's Controlled Drugs and Substances Act**

### **The Grand Paradox: Control Produces What It Fears**

The entire legal framework governing psychoactive substances in Canada is built on a grand, self-defeating paradox: the more the system attempts to control and suppress cognitive exploration through prohibition, the more it drives unregulated, dangerous exploration in the shadows. The state‚Äôs effort to protect citizens from harm becomes the very engine of that harm, creating a toxic black market, denying access to legitimate medicine, and criminalizing the fundamental human drive for self-understanding. This report deconstructs Canada's drug laws through the lens of seven core paradoxes, revealing a system that is not only ineffective but unconstitutional. The current legal field is brittle and self-defeating; a more resilient, rational, and humane approach is not only possible, but necessary.

---

### **üï∏Ô∏è 1Ô∏è‚É£ The Core Paradox: Law as Protector vs. Law as Jailor**

The Charter‚Äôs promise: Protect life, liberty, security of the person.  
Prohibition‚Äôs effect: Threatens life (toxic supply), imprisons liberty (blanket criminalization), undermines security (denial of treatment).  
**üîó Paradox 1: The legal mechanism that claims to protect you produces the very harm it says it prevents.**

The primary defense of prohibition is that it is necessary to protect public safety from the dangers of widespread drug use. This argument fails for two reasons.

First, it rests on a distorted perception of relative harm. As the data on societal costs make clear, the greatest substance-related burden on Canadian society comes from legal, regulated substances. In 2020, alcohol alone cost the Canadian economy $19.7 billion, dwarfing the costs associated with all illegal drugs combined.1 Alcohol was responsible for 17,098 deaths, compared to 6,491 for opioids.1 This demonstrates that a legal, regulated market is not inherently safer than a prohibited one; the inherent properties of the substance and its patterns of use are what drive harm. The current legal framework is inverted, permitting the most costly substance while prohibiting others with far lower societal costs.

Second, prohibition itself is a primary driver of public safety crises. The most acute drug-related danger in Canada today is the toxic, unregulated drug supply, which has been catastrophically contaminated with fentanyl and its analogues.3 This is not a natural feature of these drugs; it is a direct and foreseeable consequence of a black market created and sustained by prohibition. From 2012 to 2022, the proportion of seized opioid samples in Canada containing fentanyl or its analogues rose from 3% to 68%.3 This toxic supply is the engine of the overdose crisis, which has claimed over 40,000 lives since 2016\.5 A regulated system, by contrast, provides for quality and purity control, dose standardization, and accurate labeling‚Äîthe very safety mechanisms that prohibition makes impossible.

The argument that prohibition is necessary to protect the vulnerable also fails. This argument is paternalistic and inconsistent with legal principles applied elsewhere. Competent adults are permitted to make a vast range of choices that involve risk to their own health, from participating in extreme sports to consuming high-fat diets to smoking tobacco. The role of the state is not to eliminate all risk from adult life, but to ensure that citizens can make free and informed decisions about the risks they choose to undertake. A framework of legalization and regulation, coupled with honest public education about genuine risks, respects adult autonomy in a way that prohibition does not.

With respect to protecting youth, the evidence suggests that prohibition is a failed strategy. The Le Dain Commission noted that a "just say no" approach is often ineffective.6 The goal of cannabis legalization in Canada was, in part, to better protect youth by restricting access and eliminating the criminal element from the market.7 The data from Portugal is even more compelling: following decriminalization, rates of drug use among adolescents and young adults

*declined*.8 This suggests that a health-centered, non-punitive approach, combined with credible education, is more effective at protecting young people than a criminal justice approach that fosters fear and ignorance.

---

### **üß≠ 2Ô∏è‚É£ The Evidence Paradox: Scientific Progress vs. Legal Stagnation**

Science: New evidence says psychedelics heal trauma, treat depression, lower opioid dependence.  
Law: Ignores the evidence. The classification is frozen in 1968 moral panic.  
**üîó Paradox 2: ‚ÄúEvidence-based‚Äù policy that systematically ignores its own evidence.**

The historical arbitrariness of Canada's drug laws is thrown into even sharper relief by modern science. The *Controlled Drugs and Substances Act* operates on an implicit premise that the substances it prohibits are monolithically harmful, while those it permits, like alcohol, are acceptably safe. This premise is scientifically indefensible.

#### **The Pharmacology of Moderation vs. Abuse**

A substance's effects are not an immutable property but are profoundly dependent on dose, frequency, set, and setting. The CDSA, by imposing blanket prohibitions, fails to make these crucial distinctions, treating moderate, intentional use as legally equivalent to chronic abuse. A comparative pharmacological analysis of psychedelics, cannabis, and alcohol reveals the scientific absurdity of this legal approach.

**Psychedelics (LSD & Psilocybin):** The effects of a moderate, clinical dose of LSD (typically 75-150 micrograms) are overwhelmingly psychological.9 These include altered states of consciousness, heightened emotionality (often euphoria), enhanced introspection, and profound perceptual changes such as illusions and synesthesia.9 The minimal dose required to produce recognizable effects is as low as 25 micrograms.9 The acute somatic (physical) effects are generally mild and transient. They reflect a stimulation of the sympathetic nervous system, leading to pupil dilation, and light to moderate increases in heart rate and blood pressure.9 Importantly, there is no evidence that LSD alters liver function or is directly neurotoxic.9 While traumatic experiences or "bad trips" can occur, their likelihood is heavily influenced by the context of use; in controlled, supportive environments, the experience is more likely to have lasting positive effects on personality and well-being.9 Tolerance to LSD develops rapidly, making daily compulsive use patterns unlikely, and it has a low potential for creating physical dependence.10

Psilocybin, the active compound in "magic mushrooms," operates through similar mechanisms, primarily as a potent agonist of serotonin receptors (specifically 5-HT2A).11 Its therapeutic effects are linked not only to this receptor activity but also to its ability to decrease overactivity in the brain's default mode network (DMN)‚Äîa network associated with rumination and self-referential thought‚Äîand to promote neuroplasticity, or the brain's ability to form new connections.11 Like LSD, its risk profile is overwhelmingly psychological rather than physical, and is highly dependent on dose and setting. The concept of "microdosing"‚Äîtaking sub-hallucinogenic doses‚Äîis also gaining attention for its potential to improve mood and enhance cognitive flexibility without the profound alteration of consciousness associated with a full dose.11

**Cannabis:** The primary psychoactive compounds in cannabis, tetrahydrocannabinol (THC) and cannabidiol (CBD), act on the body's endocannabinoid system.14 The effects vary based on the route of administration, with inhalation producing rapid effects and oral ingestion leading to a slower onset but longer duration.15 While chronic, heavy cannabis use, particularly when initiated during adolescence, is associated with risks including cognitive impairment and potential exacerbation of mental health conditions, these risks are part of a complex picture.14 For many adults, moderate use for therapeutic purposes, such as pain or anxiety management, presents a very different risk-benefit calculation, one that has been deemed acceptable for legal regulation by the Canadian government itself.

**Alcohol:** In stark contrast to the pharmacological profile of psychedelics, alcohol is a known neurotoxin.16 Its mechanism of harm is direct and cumulative. Chronic heavy drinking is causally linked to a range of severe neurological conditions, including intellectual impairment, memory loss, dementia, and peripheral neuropathy.16 Even what is often considered moderate drinking carries significant risks. A recent study found that consuming eight or more alcoholic drinks per week more than doubled the risk of developing hyaline arteriolosclerosis, a condition involving the hardening of small blood vessels in the brain that leads to brain lesions associated with cognitive decline and dementia.18 Unlike psychedelics, which are typically used episodically, alcohol lends itself to a pattern of chronic, daily use that directly contributes to its substantial health burden.

This comparative analysis reveals the fundamental irrationality of the law. The CDSA treats substances like LSD and psilocybin as exceptionally dangerous, with a high potential for abuse and no accepted medical use, effectively placing them in a more restrictive category in practice than many other drugs.19 Yet, the scientific evidence shows their primary risks are psychological and context-dependent, with a low potential for the kind of physiological damage and compulsive use patterns associated with other substances. Meanwhile, alcohol‚Äîthe legal, regulated, and socially sanctioned substance‚Äîis a direct neurotoxin whose harms are severe and accumulate with chronic use. The law operates on a false, monolithic model of "harm" that ignores dose, context, and pharmacological reality. This profound mismatch between the scientific risk profile of these substances and their legal status is a central pillar of the argument that the CDSA is arbitrary and irrational, and thus fails to accord with the principles of fundamental justice.

#### **The Therapeutic and Wellness Potential of Prohibited Substances**

The irrationality of Canada's drug laws is compounded by their obstruction of legitimate medical progress. The state has a compelling interest in promoting public health and alleviating suffering from conditions like post-traumatic stress disorder (PTSD), major depression, addiction, and chronic pain. Yet, the CDSA's blanket prohibitions actively impede access to substances that a growing body of rigorous scientific evidence shows are uniquely effective treatments for these very conditions. This creates a paradoxical and self-defeating situation where a law purportedly designed to protect health in fact denies health.

**Psychedelic-Assisted Therapy:** A renaissance in psychedelic research, led by some of the world's most prestigious academic institutions, is producing powerful evidence of therapeutic efficacy.

* **Johns Hopkins Center for Psychedelic and Consciousness Research:** Since obtaining regulatory approval to resume psychedelic research in 2000, Johns Hopkins has been a global leader. Their landmark 2006 study demonstrated that a single dose of psilocybin could occasion mystical-type experiences with substantial and sustained personal meaning and spiritual significance.20 Subsequent research has shown remarkable results: psilocybin, in conjunction with cognitive behavioral therapy, helped a significant number of longtime smokers achieve abstinence where many previous attempts had failed.20 In patients with life-threatening cancer, a single large dose of psilocybin produced rapid, substantial, and enduring decreases in anxiety and depression.20 Based on this safety and efficacy data, the center's researchers have formally recommended that psilocybin be reclassified from a Schedule I drug (in the US system) to a Schedule IV drug, akin to prescription sleep aids.20 The center is now expanding its research to investigate psilocybin's potential for treating opioid addiction, PTSD, Alzheimer's disease, and anorexia nervosa.20  
* **Imperial College London Centre for Psychedelic Research:** This centre has conducted pioneering neuroimaging studies that have visualized the effects of LSD, psilocybin, and MDMA on the human brain, laying the scientific groundwork for clinical trials worldwide.23 Their clinical research has shown promising results in using psilocybin to treat severe, treatment-resistant depression.23 Building on this work, they are now conducting trials to assess the safety and feasibility of psilocybin therapy for challenging conditions like anorexia, obsessive-compulsive disorder (OCD), and fibromyalgia.23  
* **Multidisciplinary Association for Psychedelic Studies (MAPS):** MAPS has spearheaded the effort to bring psychedelic-assisted therapy into mainstream medicine through the rigorous US Food and Drug Administration (FDA) clinical trial process. Their multi-site Phase 3 trials of MDMA-assisted therapy for severe, chronic PTSD have yielded highly statistically significant results.25 In their first Phase 3 trial, an astonishing 67% of participants who received three sessions of MDMA-assisted therapy no longer met the diagnostic criteria for PTSD two months after treatment, compared to 32% in the placebo group.25 These powerful results, combined with an excellent safety profile, have positioned MDMA-assisted therapy for potential regulatory approval as a breakthrough treatment.25

**Cannabis as a Therapeutic Agent:** The therapeutic utility of cannabis is now widely recognized, a fact reflected in its legalization in Canada. Systematic reviews and meta-analyses confirm its effectiveness in managing chronic pain, particularly neuropathic pain, fibromyalgia, and the pain and spasticity associated with multiple sclerosis.27 Its role as a less harmful alternative to opioids is particularly significant. Studies have found that patients with chronic pain who use medical cannabis report substantial reductions in their use of opioid medications, with one survey finding a 64% reduction.27 Beyond pain, evidence also supports the use of cannabis for reducing anxiety and improving sleep.30

**Alcohol in Context:** To maintain a consistent, evidence-based perspective, it is also important to acknowledge that alcohol, despite its significant harms, is used by many for its psychoactive effects. Research has shown that moderate alcohol consumption in social settings can enhance positive emotions, increase social bonding, and coordinate smiling among group members.31 This is not to minimize its risks, but to frame all psychoactive substances on a spectrum of complex human tools used to alter consciousness. The legal distinction should not be a binary of "good" versus "evil," but a nuanced regulatory approach based on managing the specific risks and benefits of each tool.

The overwhelming evidence for the therapeutic potential of prohibited substances creates a profound legal and ethical dilemma for the state. By maintaining a blanket prohibition under the CDSA, the government is actively denying or severely obstructing access to treatments that are proving to be effective, and in some cases life-saving, for conditions that cause immense suffering and societal cost. This is not a theoretical harm. It is a direct deprivation of health and well-being. This state of affairs is directly analogous to the situation in *R. v. Parker*, where the court found that preventing an individual from accessing a medically necessary substance through the threat of criminal sanction was a violation of the right to security of the person that was not in accordance with the principles of fundamental justice.33 The law, in its attempt to prevent harm, is perpetuating it.

#### **The Le Dain Commission: A Path Not Taken**

At the very height of the 1960s moral panic, the Canadian government under Prime Minister Pierre Trudeau did something remarkable: it sought a rational, evidence-based assessment of the problem. In 1969, it established the Commission of Inquiry into the Non-Medical Use of Drugs, chaired by Dean Gerald Le Dain.34 The Le Dain Commission was tasked with undertaking a comprehensive investigation into the non-medical use of drugs in Canada and recommending an appropriate policy response.36

Over four years, the Commission conducted exhaustive research. It held public hearings across the country, heard from over 12,000 people, and received hundreds of submissions, including from prominent figures like John Lennon.7 The Commission's four reports, published between 1970 and 1973, represent a landmark in Canadian public policy‚Äîa thorough, thoughtful, and prescient analysis of the complex issues surrounding substance use.35

The Commission's central conclusion was a powerful indictment of the prohibitionist model. It found that the social and individual costs of criminalization‚Äîincluding the impact of a criminal record and the erosion of civil liberties through enhanced police powers‚Äîwere immense and often outweighed the harms of the drugs themselves.34 The final report emphasized that policies should discourage non-medical drug use but recommended a "gradual withdrawal of the use of the criminal law" against individuals who use drugs.35

The specific recommendations were revolutionary for their time and remain relevant today. The Commission called for the immediate decriminalization of cannabis possession and cultivation for personal use.34 For other substances, it advocated for an emphasis on treatment and medical management rather than criminal sanctions, particularly for individuals with opioid dependence.34 One commissioner, Marie-Andr√©e Bertrand, argued for an even bolder approach, recommending a policy of legal distribution and regulation for cannabis, similar to the framework for alcohol.7

Despite the report's depth and the credibility of its authors, the Trudeau government largely ignored its core recommendations.34 The political will to maintain a punitive, prohibitionist stance prevailed over the evidence-based, health-focused path laid out by the Commission. This decision cemented Canada's adherence to the "war on drugs" for another half-century, a path that was only partially reversed for cannabis in 2018, ironically by the government of the original prime minister's son.7

The rejection of the Le Dain Commission's findings is a pivotal moment in the history of Canadian drug policy. It demonstrates that the persistence of prohibition is not due to a lack of credible, evidence-based alternatives. The Canadian government was presented with a clear, rational, and humane alternative five decades ago. It made a conscious and deliberate political choice to reject that evidence. This historical fact critically undermines any contemporary government argument that the CDSA's punitive framework is a rational or necessary means of protecting public health. The government's own appointed experts concluded the opposite, and their advice was willfully ignored. This deliberate rejection of evidence underscores the fundamentally political, rather than scientific, nature of Canada's drug laws.

---

### **üß© 3Ô∏è‚É£ The Freedom Paradox: Control vs. Cognitive Liberty**

State‚Äôs position: You are free ‚Äî but you can‚Äôt choose how your own consciousness is configured.  
Cognitive Liberty: True freedom means freedom to alter your mind (as long as you don‚Äôt harm others).  
**üîó Paradox 3: You have ‚Äúfreedom of thought,‚Äù but no freedom to choose how thoughts arise.**

The critique of Canada's drug laws cannot rest solely on their historical and scientific failings. A robust constitutional challenge requires a positive assertion of a fundamental right that these laws violate. That right is cognitive liberty: the right of each individual to self-determination over their own mind and mental experiences.

#### **The Philosophical and Legal Architecture of Cognitive Liberty**

Cognitive liberty, or the "right to mental self-determination," is the principle that individuals have a sovereign right to control their own consciousness, cognition, and mental processes.37 This concept, developed and advanced by legal theorists and neuroethicists like Wrye Sententia, Richard Glen Boire, and Nita Farahany, is not merely an abstract ideal but a necessary legal principle for the 21st century.37 As technologies capable of directly monitoring and influencing the brain become more sophisticated, the need to legally protect the inner sphere of the mind becomes paramount.38

The right to cognitive liberty has two distinct but complementary facets:

1. **A Negative Right: Freedom from Interference.** This is the right to be free from non-consensual intrusion, monitoring, or manipulation of one's mental state.37 It is a shield against the state, corporations, or other actors using technology or coercion to alter an individual's thoughts, emotions, or cognitive processes against their will.37  
2. **A Positive Right: Freedom to Self-Determine.** This is the right of an individual to choose to alter or enhance their own consciousness, so long as their subsequent actions do not cause harm to others.37 This positive dimension encompasses a wide range of activities, from meditation and prayer to the use of psychoactive substances or neuro-enhancing technologies.37 It is this facet that is most directly engaged by drug prohibition.

Cognitive liberty should be understood as a crucial update to the traditional right to "freedom of thought," which is protected in international human rights instruments and implicitly in the *Charter*. While freedom of thought has historically been interpreted to protect the *content* of one's beliefs (e.g., religious or political convictions), cognitive liberty protects the *process, manner, and state* of one's mind.37 It asserts that the freedom to think

*how* one wants is a necessary precondition for the freedom to think *what* one wants. As Professor Farahany argues, cognitive liberty bridges John Locke's concept of self-ownership with John Stuart Mill's view of liberty as essential for human progress and flourishing.41

The exploration of this right is not a fringe academic exercise. It is the subject of serious legal and ethical inquiry at leading institutions. The Project on Psychedelics Law and Regulation (POPLAR), led by Professor I. Glenn Cohen at Harvard Law School, is dedicated to advancing evidence-based law and policy in this area, signaling a mainstream recognition of the complex legal questions raised by the regulation of consciousness-altering substances.42 This body of scholarship provides the robust philosophical architecture needed to ground a claim for cognitive liberty within the Canadian constitutional context.

#### **Locating Cognitive Liberty within Section 7 of the Charter**

Section 7 of the *Charter* guarantees that "Everyone has the right to life, liberty and security of the person and the right not to be deprived thereof except in accordance with the principles of fundamental justice".45 A successful challenge to the CDSA under this section requires a two-step analysis: first, demonstrating that the law deprives an individual of one of these three protected interests, and second, showing that the deprivation is not in accordance with the principles of fundamental justice (e.g., it is arbitrary, overbroad, or grossly disproportionate).45 Canadian jurisprudence provides a clear pathway for locating a right to cognitive liberty within this framework.

The foundation is built upon a series of landmark Supreme Court of Canada and appellate court decisions that have progressively broadened the scope of Section 7 to protect personal autonomy in fundamental life decisions, particularly those concerning health and the body.

* ***R. v. Morgentaler*** **(1988):** In this seminal case, the Supreme Court struck down Canada's restrictive abortion law.46 The Court found that forcing a woman to carry a pregnancy to term against her will could endanger her physical and psychological health, thereby violating her right to "security of the person".47 This decision established the foundational principle that state interference with decisions of fundamental personal importance that have a profound effect on an individual's health and psychological integrity can breach Section 7\.  
* ***R. v. Parker*** **(2000):** This Ontario Court of Appeal decision is the most direct and powerful precedent. The court considered the case of Terrance Parker, who used cannabis to control his severe epilepsy.33 It held that the absolute prohibition on cannabis possession and cultivation in the  
  *Narcotic Control Act* forced Parker to choose between his health and the threat of imprisonment.33 This choice violated his Section 7 rights to both liberty and security of the person. The court reasoned that "security of the person" must include a right of access to reasonably necessary medical treatment without fear of criminal sanction.33 Furthermore, it found the blanket prohibition, which lacked a viable medical exemption, to be overbroad and contrary to the principles of fundamental justice because it was irrational‚Äîit defeated the state's own objective of protecting health by denying a person a required medicine.33  
* ***Canada v. PHS Community Services Society*** **(2011) (the Insite Case):** Here, the Supreme Court addressed the federal government's refusal to grant a constitutional exemption to Vancouver's supervised injection site.49 The Court ruled that this refusal was arbitrary and grossly disproportionate, violating the Section 7 rights of the facility's clients.49 By denying access to a health service proven to save lives and improve health, the law was depriving individuals of their rights to life and security of the person.50 This case firmly established that the state cannot, in the name of drug policy, arbitrarily withhold health interventions that are known to be effective.

These cases create a powerful precedential convergence. *Morgentaler* establishes the principle of bodily and health autonomy. *Parker* applies this principle directly to a prohibited substance, affirming the right to access necessary medicine. The scientific evidence presented in Part II of this report demonstrates that psychedelics are, for many individuals suffering from conditions like PTSD and severe depression, a form of necessary medicine. Therefore, the CDSA's prohibition engages the right to security of the person in precisely the same way as the laws in *Parker* and *Morgentaler*.

Cognitive liberty provides the framework to expand this from a narrow "medical necessity" argument to a broader "liberty" argument. The right to liberty under Section 7 has been interpreted to include the freedom to make fundamental personal choices free from state interference.51 The decision to tend to one's own mind, to "compost trauma," to seek spiritual insight, or to engage in profound self-exploration through the intentional use of a psychoactive substance is a matter of the most fundamental personal importance. It goes to the core of an individual's autonomy and their right to shape their own consciousness and identity. By criminalizing this choice, the CDSA deprives individuals of this core aspect of liberty.

This argument must, however, contend with the Supreme Court's decision in ***R. v. Malmo-Levine; R. v. Caine*** **(2003)**, which upheld the general prohibition on cannabis possession.52 In that case, the Court rejected the "harm principle" (the idea that the criminal law should only prohibit conduct that harms others) as a principle of fundamental justice.52 It held that Parliament only needed to demonstrate a "reasonable apprehension of harm" to justify the law, and found that the risks associated with cannabis use (e.g., impaired driving, harm to vulnerable groups) met this low threshold.53

A successful challenge must distinguish itself from *Malmo-Levine* on several grounds. First, the argument advanced here is not for an unlimited right to recreational use, but for a right to access these substances for specific, deeply personal purposes of health, wellness, and cognitive self-determination, which engages Section 7 more profoundly. Second, the wealth of high-quality scientific evidence for therapeutic benefit that exists today for psychedelics simply did not exist for cannabis in 2003, making the *Parker* line of reasoning far more potent. The current state of evidence makes the blanket prohibition appear far more arbitrary and irrational than it may have seemed two decades ago. Third, the argument is that the absolute prohibition is *grossly disproportionate* to the state's objective, a standard of review that the *Malmo-Levine* court acknowledged could invalidate a law. Given the demonstrable benefits being denied and the proven success of less intrusive models (as discussed below), the current prohibition fails this test.

| Case Name | Year | Core Ruling | Key Principle for Cognitive Liberty Argument |
| :---- | :---- | :---- | :---- |
| ***R. v. Morgentaler*** 46 | 1988 | Struck down restrictive abortion law as a violation of security of the person. | Established that state interference with fundamental personal health decisions that impacts psychological and physical integrity can violate Section 7\. |
| ***R. v. Parker*** 33 | 2000 | Found that forcing a choice between health (medical cannabis) and imprisonment violated liberty and security of the person. | Affirmed a right of access to necessary medical treatment, even if the substance is prohibited, and found a blanket prohibition without a viable exemption to be irrational and overbroad. |
| ***Canada v. PHS (Insite)*** 49 | 2011 | Ruled that denying an exemption for a supervised injection site was arbitrary and violated the life and security rights of its clients. | Confirmed that the state cannot arbitrarily withhold access to proven, life-saving health interventions under the guise of drug policy. |
| ***R. v. Malmo-Levine*** 52 | 2003 | Upheld the general prohibition on cannabis possession, rejecting the "harm principle" as a principle of fundamental justice. | Established a low threshold of "reasonable apprehension of harm" for Parliament to justify criminalization. Must be distinguished based on new evidence and a focus on health/autonomy, not just recreation. |
|   |  |  |  |

---

### **‚öñÔ∏è 4Ô∏è‚É£ The Moral Paradox: Harm vs. Moral Panic**

Alcohol: Proven neurotoxin, legal, normalized, taxed.  
Psychedelics: Low physical toxicity, high therapeutic promise, illegal, demonized.  
**üîó Paradox 4: The more harmful the substance (culturally normalized), the more legal it is; the less harmful (marginalized), the more illegal.**

The legal architecture governing psychoactive substances in Canada is not, as is often presumed, the product of a dispassionate, scientific assessment of risk. Rather, it is a historical artifact, constructed upon foundations of racial prejudice, social control, and moral panic. An examination of this history reveals that the differential criminalization of various substances‚Äîthe legality of alcohol versus the strict prohibition of psychedelics, for instance‚Äîis fundamentally arbitrary. This arbitrariness, born of historical contingency rather than rational public health policy, renders the current legislative framework, the *Controlled Drugs and Substances Act* (CDSA), profoundly vulnerable to constitutional challenge.

#### **A History of Differential Criminalization**

The genesis of drug prohibition in Canada is inextricably linked to racial animus and the desire to control marginalized populations. Before the turn of the 20th century, substances like opium, cannabis, and cocaine were legal and commonly used for both medicinal and relaxation purposes.34 The legislative shift towards prohibition was not precipitated by a public health crisis but by a crisis of social hierarchy. The first major piece of drug legislation,

*The Opium Act, 1908*, was passed in the direct aftermath of an anti-Asian race riot in Vancouver and was explicitly targeted at Chinese immigrants.34 These immigrants, who had been instrumental in building the Canadian Pacific Railway, used opium for pain relief and relaxation. The prohibition was fueled by economic anxiety from domestic workers who saw Chinese men as competition and by racist fears about the supposed moral corruption of white women through contact with Chinese men in opium dens.34 This law, therefore, was not a health measure but a tool of social engineering, establishing a precedent that would define Canadian drug policy for a century: the legal status of a substance was determined not by its intrinsic properties, but by the social status of those who used it.34

This pattern continued with the *Opium and Drug Act* of 1911, which added cocaine and morphine to the list of prohibited substances and expanded police powers, and the subsequent addition of cannabis and 15 other substances over the next 50 years.34 The legislative framework grew increasingly punitive, culminating in the

*Narcotic Control Act* of 1961, which increased penalties and, in alignment with the UN *Single Convention on Narcotic Drugs*, made simple possession a punishable offense.34

The history of alcohol prohibition provides a stark and telling contrast. The movement to ban alcohol was driven by a different set of social forces: the temperance movement, which was rooted in a particular vision of Christian morality and sobriety, and was connected to other reform efforts like women's suffrage.56 The

*Canada Temperance Act* of 1878 gave local governments a "local option" to ban alcohol sales, a far cry from the absolute federal prohibitions imposed on substances used by racialized groups.57 While province-wide prohibition became widespread during the First World War, framed as a patriotic duty, it was a relatively short-lived experiment.57 Quebec rejected prohibition in 1919, and most other provinces had repealed their policies by the late 1920s.56

The differential treatment is revealing. The legal framework for alcohol was more flexible, its prohibition was temporary, and its repeal was swift. This demonstrates a societal and political capacity to reverse the prohibition of a substance deeply embedded in the dominant European culture, despite its well-documented harms. For substances associated with marginalized groups, however, prohibition became a permanent and increasingly punitive fixture of the Canadian legal landscape. The modern CDSA, enacted in 1996, consolidated these historical prohibitions into a single statute, creating schedules for different substances but maintaining the fundamental architecture of criminalization and punishment, including severe penalties like imprisonment for possession of substances in Schedules I, II, or III.34

This legislative lineage is not a neutral historical fact; it is a critical flaw in the foundation of the law. The CDSA is the direct descendant of laws whose origins are not in public health but in racial discrimination. While the motivations of past legislators do not automatically invalidate a modern law, they expose the absence of a rational, evidence-based justification for the legislative distinctions that persist to this day. The fact that alcohol is legal and regulated while psilocybin is strictly prohibited is not a historical accident; it is the logical continuation of a century-old pattern of arbitrary social control, where the perceived identity of the user, not the scientifically assessed risk of the substance, dictates its legal status. This "tainted origin" undermines any claim that the CDSA's classifications are rationally connected to a public health objective, a key vulnerability in a constitutional challenge under Section 7 of the *Charter*.

| Substance | Legal Status in Canada | Societal Cost (2020) 1 | Attributable Deaths (2020) 1 | Documented Therapeutic Potential |
| :---- | :---- | :---- | :---- | :---- |
| **Alcohol** | Legal & Regulated | $19.7 billion | 17,098 | Minimal; moderate use linked to social bonding.31 |
| **Tobacco** | Legal & Regulated | $11.2 billion | 46,366 | None |
| **Opioids** | Prescription (Legal); Unregulated (Illegal) | $7.1 billion | 6,491 | High (analgesia) |
| **Cannabis** | Legal & Regulated | $2.4 billion | (Not specified) | High (chronic pain, anxiety, opioid-sparing).27 |
| **LSD/Psilocybin** | CDSA Schedule III (Prohibited) 58 | Negligible | Negligible | High (depression, PTSD, anxiety, addiction).20 |
|   |  |  |  |  |

#### **The 1960s Moral Panic and the Criminalization of Psychedelics**

The prohibition of psychedelics like lysergic acid diethylamide (LSD) offers another case study in how cultural anxiety, rather than scientific evidence, has shaped Canadian drug law. In the 1950s and early 1960s, LSD was not a public menace but a promising frontier of psychiatric research. In Saskatchewan, with the support of the provincial Co-operative Commonwealth Federation (CCF) government, researchers such as Humphry Osmond and Abram Hoffer conducted pioneering studies.59 They explored LSD's potential as a "psychotomimetic" to model psychosis and build empathy, and, most notably, as a powerful adjunct to therapy for treating chronic alcoholism, achieving remarkable success rates.60 At this stage, LSD was a legitimate tool of medical science, distributed legally and studied with government sanction.59

This scientific narrative was completely derailed by the mid-1960s as non-medical use of LSD became inextricably linked with the burgeoning youth counter-culture. This "hippie" movement, with its anti-authoritarian politics, anti-war sentiments, and alternative lifestyles, was perceived by the mainstream as a profound threat to the established social and moral order.62 LSD became the sacrament of this counter-culture, and as such, it was transformed in the public imagination from a therapeutic agent into a dangerous, society-destroying poison.59

The media was instrumental in fanning the flames of this "moral panic," a sociological phenomenon characterized by an exaggerated public concern over a perceived threat that is disproportionate to its actual danger.63 Sensationalist news coverage amplified fears, spreading lurid anecdotes and outright misinformation, such as the widely publicized but scientifically unfounded claim that LSD damaged chromosomes.59 Press coverage described the drug as "a monster that shrank the brain".59 This hysteria effectively eroded the authority of medical experts who had actual experience with the substance. Researchers like Osmond and Hoffer, who argued for a nuanced, regulated approach, found themselves drowned out by the "profound yet meaningless statements" of politicians and commentators who had no experience with the drug but were certain of its dangers.61

The debate shifted decisively from the laboratory to the political arena. The association with the Thalidomide tragedy in 1962, though scientifically unwarranted, created a political opening to reclassify LSD as a prohibited substance.61 As non-medical use grew, the pressure for decisive political action mounted, culminating in Canada making LSD completely illegal in 1968\.60

This history reveals a critical pattern in Canadian drug policy: the political weaponization of drug laws. The criminalization of LSD was not a response to new scientific evidence of its harm; it was a political response to its cultural symbolism. The law was used as a tool to marginalize and suppress a social group‚Äîthe counter-culture‚Äîwhose values and politics were deemed threatening to the establishment.62 This mirrors the earlier use of opium laws to target Chinese immigrants. In both cases, when a substance becomes associated with a politically inconvenient or socially marginalized group, the state's response is not regulation or public health intervention, but prohibition and criminalization. This historical reality directly refutes any claim that the CDSA's scheduling is based on a rational, objective assessment of risk. It demonstrates, instead, that the law is a product of political expediency and cultural prejudice, making it fundamentally arbitrary.

---

### **üß¨ 5Ô∏è‚É£ The Observer Paradox: The Law Watches the Mind**

*Under the Charter, your mind is supposed to be your private domain. Under digital surveillance, smart devices, and prohibition, your mind becomes a domain to be watched, policed, predicted, and punished.*

**üîó Paradox 5: You are both the observer of your consciousness and the observed by the state.**

Jurisprudence on the right to privacy under Section 8 of the *Charter*, while distinct, informs the liberty interest under Section 7\. Cases concerning workplace drug testing and digital privacy have affirmed that Canadians have a reasonable expectation of privacy over their bodies and personal information, though this right must be balanced against countervailing state interests like public safety.65 The choice to alter one's own consciousness, particularly within the privacy of one's home or a controlled therapeutic setting, lies at the very heart of the "biographical core of personal information" that the right to privacy is meant to protect. The state's interest in policing this internal domain creates a paradox where the individual is simultaneously the subject of their own experience and the object of state surveillance.

---

### **üîÑ 6Ô∏è‚É£ The Field Paradox: Stabilization vs. Entropy**

*A monotropic legal field is designed to stay stable by preventing divergence. But reality (drug innovation, cultural shifts, scientific proof) keeps adding energy to the system ‚Äî so the field must either open into a multi-channel system (Portugal, harm reduction), or collapse into chaotic entropy (toxic supply, mass incarceration, overdoses).*

**üîó Paradox 6: Over-regulation creates instability because it locks the system into a brittle state.**

If a court finds that the CDSA's prohibitions on psychedelics violate Section 7, the government's final recourse is to argue under Section 1 of the *Charter* that the law is a "reasonable limit... demonstrably justified in a free and democratic society." To succeed, the government must prove, among other things, that the law is rationally connected to its objective (protecting public health) and that it is "minimally impairing"‚Äîthat is, it infringes on the right no more than is necessary to achieve its objective. The existence of a proven, effective, and less rights-infringing policy alternative makes this an exceptionally difficult burden for the government to meet. That alternative is a public health framework centered on harm reduction.

Harm reduction is a pragmatic and evidence-based approach to substance use. It is built on principles of public health and human rights, accepting that some level of drug use is an inevitable part of society and choosing to minimize its negative consequences rather than simply condemning or ignoring it.68 It prioritizes the quality of life and well-being of individuals and communities, and respects the autonomy of people who use drugs by meeting them "where they're at" without judgment or coercion.69 This approach is not theoretical; it has been successfully implemented on a national scale.

**The Portugal Model: A Case Study in Success:** In 2001, facing a devastating public health crisis driven by heroin addiction, including the highest rate of drug-related AIDS in the European Union, Portugal took a radical step: it decriminalized the personal use and possession of all illicit drugs.70 This was not legalization. Trafficking and distribution remain serious criminal offenses. Instead, individuals found in possession of a personal supply (defined as up to a ten-day quantity) are no longer sent to the criminal justice system. They are referred to a "Dissuasion Commission," a regional administrative panel composed of a lawyer, a doctor, and a social worker.71 These commissions assess the individual's situation and can recommend voluntary treatment, but sanctions are rare and non-punitive.71

Critically, decriminalization was paired with a massive expansion of and investment in public health infrastructure, including treatment, harm reduction services (like needle exchanges and opioid substitution therapy), and social reintegration programs.71

The results have been an unambiguous public health success.

* **Overdose Deaths:** Drug-related deaths plummeted. Between 1999 and 2015, overdose deaths fell by over 80%.71 As of 2019, Portugal's drug death rate was 6 deaths per million, compared to the EU average of 23.7 per million.72  
* **HIV Infections:** New HIV diagnoses among people who inject drugs dropped dramatically. In 2000, they accounted for 52% of new HIV cases in Portugal; by 2015, that figure was just 6%.71  
* **Criminal Justice System:** The burden on the justice system was significantly reduced. The proportion of the prison population sentenced for drug offenses fell from over 40% in 2001 to 15.7% in 2019, a figure now below the European average.72 Arrests for drug possession fell from over 14,000 in 2000 to an average of 5,500-6,000 per year post-reform.8  
* **Drug Use:** The dire predictions of an explosion in drug use did not materialize. While lifetime prevalence has seen some increase, in line with trends in other European countries, rates of problematic drug use and use among youth have declined.8

The success of the Portugal model provides a powerful real-world demonstration that a less intrusive, health-focused approach is not only possible but is demonstrably *more effective* at achieving the state's legitimate public health and safety objectives than a prohibitionist criminal justice model. This is not merely a policy alternative; in the context of a *Charter* challenge, it is crucial evidence. It allows a court to conclude that the CDSA's blanket prohibitions are not minimally impairing. A proven, less rights-infringing, and more successful model exists. Therefore, the current law cannot be saved under Section 1\. This argument is already gaining traction in Canada, with the decriminalization pilot in British Columbia and persistent calls from public health bodies and advocacy groups for a national health-based strategy.5

| Metric | Pre-Decriminalization (c. 1999-2001) | Post-Decriminalization (Latest Available Data) | Outcome |
| :---- | :---- | :---- | :---- |
| **Drug-Related Deaths** | 369 deaths (1999) 71 | 76 deaths (2001) to 16 deaths (2012) 8; Rate of 6/million vs EU avg. of 23.7/million (2019) 72 | Significant and sustained decrease. |
| **New HIV Infections (among PWUD)** | 1,430 cases (52% of total) in 2000 71 | 56 cases (2012) 8; 77 cases (6% of total) in 2015 71 | Dramatic reduction. |
| **Drug-Related Incarceration Rate** | 40-44% of prison population (1999-2001) 8 | 15.7% of prison population (2019) 72 | Dramatic reduction. |
| **Individuals in Treatment** | Increased significantly post-reform 71 | 17,246 in Opioid Substitution Treatment (latest data) 72 | Increased access and engagement with health services. |
|   |  |  |  |

---

### **üóùÔ∏è 7Ô∏è‚É£ The Constitutional Paradox: Charter Supremacy vs. International Treaties**

*International drug treaties defer to ‚Äúconstitutional principles and basic concepts of legal systems.‚Äù The Charter says your rights come first.*

**üîó Paradox 7: Canada claims to protect your Charter rights while enforcing an international system that explicitly says ‚ÄúDon‚Äôt violate your Charter rights.‚Äù**

Canada's domestic drug laws do not exist in a vacuum; they are heavily influenced by a framework of international treaties. Canada is a signatory to the three core United Nations drug control conventions: the *Single Convention on Narcotic Drugs, 1961*, the *Convention on Psychotropic Substances, 1971*, and the *Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988*.74 The primary goal of these treaties is to establish a coordinated international system to combat drug abuse by limiting the possession, trade, and production of scheduled substances exclusively to medical and scientific purposes.75

On its face, this international framework appears to mandate the kind of prohibitionist regime embodied by the CDSA. However, a closer examination of the treaties and their historical context reveals significant flexibility‚Äîflexibility that Canada has largely chosen to ignore in favor of a maximally punitive approach.

Crucially, the conventions themselves contain provisions that subordinate their obligations to the domestic legal and constitutional frameworks of signatory nations. Article 3, paragraph 2 of the 1988 Convention, which obliges parties to establish personal possession as a criminal offense, is explicitly qualified. It states that this obligation is "subject to its constitutional principles and the basic concepts of its legal system".77 This clause serves as an explicit acknowledgment that domestic constitutional law‚Äîsuch as the

*Canadian Charter of Rights and Freedoms*‚Äîcan and should shape the implementation of international treaty obligations. It provides a clear textual basis for an argument that a domestic prohibition that violates fundamental constitutional rights cannot be justified by pointing to the treaty.

Furthermore, Canada's path to the current CDSA was a series of policy choices, not foregone conclusions. At the 1971 Vienna conference that produced the Convention on Psychotropic Substances, nations were split into factions. One group, composed largely of developed nations with powerful pharmaceutical industries, had different interests and priorities than the developing nations that had been economically impacted by the 1961 Convention's restrictions on plant-based drugs.78 Canada was not a passive recipient of international directives; it was an active participant. In fact, Canada had already moved to place "restricted substances" like LSD under federal control in 1969, two years

*before* the 1971 Convention was finalized.78 The subsequent enactment of the CDSA in 1996 was a domestic policy decision to consolidate and continue a prohibitionist approach, consistent with the broader "war on drugs" ideology, rather than the only possible way to fulfill its international commitments.34

The enactment of the *Charter* in 1982 fundamentally altered the Canadian legal landscape. As the supreme law of the country, the *Charter* imposes a new and overriding set of constraints on all government action, including the implementation of international treaties. The CDSA, as the domestic expression of pre-*Charter* international agreements, is not immune from this scrutiny. The argument is not that Canada should abrogate its treaty responsibilities, but that its method of fulfilling them must be *Charter*\-compliant. A prohibition that is found to be arbitrary, overbroad, or grossly disproportionate in its effects on the rights to life, liberty, and security of the person under Section 7 cannot be saved by an appeal to an international framework that explicitly defers to domestic constitutional principles. The *Charter* provides the definitive lens through which these international obligations must now be interpreted and implemented.

### **Conclusion and Recommendations**

The prohibition of certain psychoactive substances, such as LSD and psilocybin, under Canada's *Controlled Drugs and Substances Act* is unconstitutional. The legal framework, which permits and regulates the highly harmful substance alcohol while imposing a blanket criminal prohibition on substances with demonstrated therapeutic potential, is irrational and arbitrary. This differential treatment is not the result of a rational, evidence-based assessment of relative risk but is a legacy of historical prejudice, racial discrimination, and moral panic, which are impermissible foundations for a law that infringes fundamental rights.

Modern science confirms this irrationality. It reveals a clear pharmacological distinction between the moderate, intentional use of psychedelics and the chronic abuse of neurotoxins like alcohol. The scientific evidence also establishes the significant and, in some cases, unparalleled therapeutic potential of prohibited substances for treating debilitating conditions such as PTSD, treatment-resistant depression, and addiction. By criminalizing these substances, the CDSA deprives Canadians of their Section 7 right to security of the person, which includes the right to make fundamental personal health decisions and access necessary medical treatment. The law forces an unconscionable choice between health and imprisonment, a direct violation of the principles established in *R. v. Parker*.

Furthermore, the prohibition infringes the Section 7 right to liberty, which must be interpreted to include a right to cognitive liberty‚Äîthe right to self-determination over one's own consciousness and mental experiences. The decision to explore one's own mind for the purposes of healing, growth, or spiritual inquiry is a matter of fundamental personal importance that the state cannot criminalize without a compelling and rational justification.

This multifaceted violation of Section 7 cannot be saved under Section 1 of the *Charter*. The law is not rationally connected to its stated public health objective; indeed, it is often counterproductive, denying access to beneficial treatments and fostering a dangerous unregulated market. Most critically, the law is not minimally impairing. The success of the comprehensive harm reduction model implemented in Portugal provides dispositive proof that a less rights-infringing alternative not only exists but is far more effective at protecting public health and safety. Therefore, the current prohibitionist regime is an unconstitutional overreach of state power that must be struck down and replaced with a rational, evidence-based, and rights-respecting framework.

#### **Recommendations for a New Legislative and Regulatory Framework**

A declaration that the current prohibitions are unconstitutional should not create a legal vacuum or a commercial free-for-all. It should, rather, compel Parliament to create a new, nuanced, and evidence-based legislative and regulatory framework that balances liberty with public health. Such a framework should be guided by the principles of harm reduction and should be tailored to the specific risks and benefits of different substances and contexts of use. The following recommendations outline a potential path forward.

1. **Legislative Reform of the *Controlled Drugs and Substances Act***:  
   * Parliament should amend the CDSA to remove classic psychedelics, including psilocybin and LSD, from Schedule III. This would end the criminal prohibition on their possession and production.  
   * In its place, Parliament should create a new legislative authority for Health Canada to develop distinct regulatory streams for these substances, recognizing their unique properties and uses.  
2. **A Tiered Regulatory Model for Access:**  
   * **Psychedelic-Assisted Therapy:** A formal medical stream should be established to regulate the use of psychedelics as an adjunct to psychotherapy. This would involve creating licensing standards for therapists and clinical facilities, developing protocols for treatment based on the models established in clinical trials by organizations like MAPS and research at Johns Hopkins, and ensuring that access is integrated into the provincial healthcare systems.  
   * **Spiritual and Wellness Use:** A non-medical, professionalized stream should be created to regulate the use of psychedelics in spiritual or wellness contexts. This would involve a licensing system for trained and qualified facilitators and retreat centers, with strict safety protocols, screening procedures for participants, and codes of ethical conduct. This model can draw from the existing Section 56 exemption process that has already been granted to some ayahuasca churches, but should be made more accessible and standardized.79  
   * **Personal Use:** For personal possession and use outside of a therapeutic or facilitated context, Canada should adopt a decriminalization model based on the success of Portugal. Possession of a personal quantity of a substance would no longer be a criminal offense. Instead, it would be an administrative matter, with an emphasis on providing education, health resources, and voluntary treatment options, diverting individuals away from the criminal justice system entirely.  
3. **Massive Investment in Public Health and Education:**  
   * Any legal reform must be accompanied by a significant and sustained public investment in harm reduction, treatment, and education. This includes funding for a wide range of services, from supervised consumption sites and drug-checking services to accessible, on-demand treatment for substance use disorders.  
   * A national public education campaign should be launched to provide Canadians with honest, science-based information about the risks and potential benefits of all psychoactive substances, moving away from fear-based messaging towards a culture of informed and responsible decision-making.

The current legal paradigm for controlled substances in Canada is a failure. It is a failure of history, of science, and of constitutional law. It is rooted in prejudice, blind to evidence, and corrosive to the fundamental rights of citizens. The time has come to dismantle this arbitrary and harmful regime and replace it with a policy that is rational, humane, and consistent with the core values of liberty, security, and justice enshrined in the *Charter*.

#### **Works cited**

1. Substance Use Costs in Canada in 2020 \- CSUCH, accessed July 14, 2025, [https://csuch.ca/substance-use-costs/current-costs/](https://csuch.ca/substance-use-costs/current-costs/)  
2. Canadian Substance Use Costs and Harms 2007‚Äì2020 \- CSUCH, accessed July 14, 2025, [https://csuch.ca/assets/documents/reports/english/Canadian-Substance-Use-Costs-and-Harms-Report-2007-2020-en.pdf](https://csuch.ca/assets/documents/reports/english/Canadian-Substance-Use-Costs-and-Harms-Report-2007-2020-en.pdf)  
3. The evolving potency of Canada's unregulated opioid supply \- CATIE.ca, accessed July 14, 2025, [https://www.catie.ca/catie-news/the-evolving-potency-of-canadas-unregulated-opioid-supply](https://www.catie.ca/catie-news/the-evolving-potency-of-canadas-unregulated-opioid-supply)  
4. Canada's overdose crisis and the toxic illegal drug supply, accessed July 14, 2025, [https://www.canada.ca/en/health-canada/services/opioids/overdose-crisis-toxic-illegal-drug-supply.html](https://www.canada.ca/en/health-canada/services/opioids/overdose-crisis-toxic-illegal-drug-supply.html)  
5. Canadian Drug Policy Coalition, accessed July 14, 2025, [https://drugpolicy.ca/](https://drugpolicy.ca/)  
6. 1969 \- 1973 CE Le Dain Commission, Canada \- Drug History Timeline, accessed July 14, 2025, [https://drugtimeline.ca/event/le-dain-commission-canada/](https://drugtimeline.ca/event/le-dain-commission-canada/)  
7. Le Dain Commission of Inquiry into the Non-Medical Use of Drugs \- Wikipedia, accessed July 14, 2025, [https://en.wikipedia.org/wiki/Le\_Dain\_Commission\_of\_Inquiry\_into\_the\_Non-Medical\_Use\_of\_Drugs](https://en.wikipedia.org/wiki/Le_Dain_Commission_of_Inquiry_into_the_Non-Medical_Use_of_Drugs)  
8. Drug decriminalisation in Portugal: setting the record straight \- UNODC, accessed July 14, 2025, [https://www.unodc.org/documents/ungass2016/Contributions/Civil/Transform-Drug-Policy-Foundation/Drug-decriminalisation-in-Portugal.pdf](https://www.unodc.org/documents/ungass2016/Contributions/Civil/Transform-Drug-Policy-Foundation/Drug-decriminalisation-in-Portugal.pdf)  
9. The Pharmacology of Lysergic Acid Diethylamide: A Review \- PMC, accessed July 14, 2025, [https://pmc.ncbi.nlm.nih.gov/articles/PMC6494066/](https://pmc.ncbi.nlm.nih.gov/articles/PMC6494066/)  
10. LSD \- Alcohol and Drug Foundation, accessed July 14, 2025, [https://adf.org.au/drug-facts/lsd/](https://adf.org.au/drug-facts/lsd/)  
11. Mushrooms, Microdosing, and Mental Illness: The Effect of ..., accessed July 14, 2025, [https://www.dovepress.com/mushrooms-microdosing-and-mental-illness-the-effect-of-psilocybin-on-n-peer-reviewed-fulltext-article-NDT](https://www.dovepress.com/mushrooms-microdosing-and-mental-illness-the-effect-of-psilocybin-on-n-peer-reviewed-fulltext-article-NDT)  
12. Neural mechanisms underlying psilocybin's therapeutic potential ‚Äì the need for preclinical in vivo electrophysiology \- PubMed Central, accessed July 14, 2025, [https://pmc.ncbi.nlm.nih.gov/articles/PMC9247433/](https://pmc.ncbi.nlm.nih.gov/articles/PMC9247433/)  
13. This Is Your Brain on Microdoses of Psilocybin \- Psychology Today, accessed July 14, 2025, [https://www.psychologytoday.com/us/blog/the-athletes-way/201811/this-is-your-brain-on-microdoses-of-psilocybin](https://www.psychologytoday.com/us/blog/the-athletes-way/201811/this-is-your-brain-on-microdoses-of-psilocybin)  
14. Long-term effects of cannabis \- Wikipedia, accessed July 14, 2025, [https://en.wikipedia.org/wiki/Long-term\_effects\_of\_cannabis](https://en.wikipedia.org/wiki/Long-term_effects_of_cannabis)  
15. Pharmacology of Marijuana \- OMICS International, accessed July 14, 2025, [https://www.omicsonline.org/open-access/pharmacology-of-marijuana-2155-6105-S11-012.php?aid=84733](https://www.omicsonline.org/open-access/pharmacology-of-marijuana-2155-6105-S11-012.php?aid=84733)  
16. Alcohol's effect on the body \- Mayo Clinic Health System, accessed July 14, 2025, [https://www.mayoclinichealthsystem.org/hometown-health/speaking-of-health/does-drinking-alcohol-kill-brain-cells](https://www.mayoclinichealthsystem.org/hometown-health/speaking-of-health/does-drinking-alcohol-kill-brain-cells)  
17. Alcohol related brain impairment | Better Health Channel, accessed July 14, 2025, [https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/alcohol-related-brain-impairment](https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/alcohol-related-brain-impairment)  
18. Heavy and Even Moderate Drinking Can Harm the Brain, Study Finds \- Everyday Health, accessed July 14, 2025, [https://www.everydayhealth.com/neurological-disorders/heavy-and-moderate-drinking-can-harm-the-brain/](https://www.everydayhealth.com/neurological-disorders/heavy-and-moderate-drinking-can-harm-the-brain/)  
19. Q1. How has drug legislation changed recently? \- Drug Use and Offending, accessed July 14, 2025, [https://www.justice.gc.ca/eng/rp-pr/csj-sjc/jsp-sjp/qa02\_2-qr02\_2/p1.html](https://www.justice.gc.ca/eng/rp-pr/csj-sjc/jsp-sjp/qa02_2-qr02_2/p1.html)  
20. Johns Hopkins Center for Psychedelic and Consciousness Research, accessed July 14, 2025, [https://www.hopkinsmedicine.org/psychiatry/research/psychedelics-research](https://www.hopkinsmedicine.org/psychiatry/research/psychedelics-research)  
21. Chronic Low Back Pain ‚Äî Center for Psychedelic & Consciousness Research, accessed July 14, 2025, [https://hopkinspsychedelic.org/backpain](https://hopkinspsychedelic.org/backpain)  
22. Johns Hopkins Psychedelic Research, accessed July 14, 2025, [https://hopkinspsychedelic.org/](https://hopkinspsychedelic.org/)  
23. Research | Research groups | Imperial College London, accessed July 14, 2025, [https://www.imperial.ac.uk/psychedelic-research-centre/research/](https://www.imperial.ac.uk/psychedelic-research-centre/research/)  
24. About the Centre and CIPPRes | Research groups \- Imperial College London, accessed July 14, 2025, [https://www.imperial.ac.uk/psychedelic-research-centre/about/](https://www.imperial.ac.uk/psychedelic-research-centre/about/)  
25. Clinical Trial Data Publications ‚Äì Multidisciplinary Association for ..., accessed July 14, 2025, [https://maps.org/category/research/research-papers/trial-results/](https://maps.org/category/research/research-papers/trial-results/)  
26. A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) | ClinicalTrials.gov, accessed July 14, 2025, [https://clinicaltrials.gov/study/NCT03537014](https://clinicaltrials.gov/study/NCT03537014)  
27. Cannabinoids in Chronic Pain Management: A Review of the History ..., accessed July 14, 2025, [https://www.mdpi.com/2227-9059/13/3/530](https://www.mdpi.com/2227-9059/13/3/530)  
28. CBD oil for pain management: Effects, benefits, and uses \- Medical News Today, accessed July 14, 2025, [https://www.medicalnewstoday.com/articles/319475](https://www.medicalnewstoday.com/articles/319475)  
29. Therapeutic Effects of Cannabis and Cannabinoids \- NCBI, accessed July 14, 2025, [https://www.ncbi.nlm.nih.gov/books/NBK425767/](https://www.ncbi.nlm.nih.gov/books/NBK425767/)  
30. Full article: Changes in Pain and Mental Health Symptoms Associated with Prescribed Medicinal Cannabis Use: A One-Year Longitudinal Study, accessed July 14, 2025, [https://www.tandfonline.com/doi/full/10.1080/15360288.2024.2414898](https://www.tandfonline.com/doi/full/10.1080/15360288.2024.2414898)  
31. Study Shows Moderate Alcohol Consumption Enhances Social Bonding, accessed July 14, 2025, [https://www.psychologicalscience.org/news/study-shows-moderate-alcohol-consumption-enhances-social-bonding.html](https://www.psychologicalscience.org/news/study-shows-moderate-alcohol-consumption-enhances-social-bonding.html)  
32. University of Pittsburgh Study Reveals Moderate Doses of Alcohol Increase Social Bonding in Groups, accessed July 14, 2025, [https://www.news.pitt.edu/Alcohol\_Social\_Bonding](https://www.news.pitt.edu/Alcohol_Social_Bonding)  
33. R v. Parker \- Global Health & Human Rights Database |, accessed July 14, 2025, [https://www.globalhealthrights.org/r-v-parker/](https://www.globalhealthrights.org/r-v-parker/)  
34. Detailed summary of the history of Canadian Drug Policy. \- Simcoe ..., accessed July 14, 2025, [https://www.simcoemuskokahealth.org/docs/default-source/TOPIC\_Drugs/appendix-d---history-of-drug-policy-in-canada.pdf?sfvrsn=2](https://www.simcoemuskokahealth.org/docs/default-source/TOPIC_Drugs/appendix-d---history-of-drug-policy-in-canada.pdf?sfvrsn=2)  
35. Royal Commission on the Non-medical Use of Drugs | The Canadian Encyclopedia, accessed July 14, 2025, [https://www.thecanadianencyclopedia.ca/en/article/royal-commission-on-the-non-medical-use-of-drugs](https://www.thecanadianencyclopedia.ca/en/article/royal-commission-on-the-non-medical-use-of-drugs)  
36. 4.3 Canadian Commissions, Committees & Task Forces on Drugs ‚Äì Psychoactive Substance Use and Social Policy \- eCampusOntario Pressbooks, accessed July 14, 2025, [https://ecampusontario.pressbooks.pub/psychoactivesubstancesvls1/chapter/4-3-canadian-commissions-committees-task-forces-on-drugs-2/](https://ecampusontario.pressbooks.pub/psychoactivesubstancesvls1/chapter/4-3-canadian-commissions-committees-task-forces-on-drugs-2/)  
37. Cognitive liberty \- Wikipedia, accessed July 14, 2025, [https://en.wikipedia.org/wiki/Cognitive\_liberty](https://en.wikipedia.org/wiki/Cognitive_liberty)  
38. The Battle for Your Brain: A Legal Scholar's Argument for Protecting Brain Data and Cognitive Liberty | Judicature, accessed July 14, 2025, [https://judicature.duke.edu/articles/the-battle-for-your-brain-a-legal-scholars-argument-for-protecting-brain-data-and-cognitive-liberty/](https://judicature.duke.edu/articles/the-battle-for-your-brain-a-legal-scholars-argument-for-protecting-brain-data-and-cognitive-liberty/)  
39. Achieving cognitive libertyThe Battle for Your Brain: Defending the Right to Think Freely in the Age of Neurotechnology Nita A. Farahany St. Martin's Press, 2023\. 288 pp \- ResearchGate, accessed July 14, 2025, [https://www.researchgate.net/publication/369327061\_Achieving\_cognitive\_liberty\_The\_Battle\_for\_Your\_Brain\_Defending\_the\_Right\_to\_Think\_Freely\_in\_the\_Age\_of\_Neurotechnology\_Nita\_A\_Farahany\_St\_Martin's\_Press\_2023\_288\_pp](https://www.researchgate.net/publication/369327061_Achieving_cognitive_liberty_The_Battle_for_Your_Brain_Defending_the_Right_to_Think_Freely_in_the_Age_of_Neurotechnology_Nita_A_Farahany_St_Martin's_Press_2023_288_pp)  
40. Cognitive liberty ‚Äì Knowledge and References \- Taylor & Francis, accessed July 14, 2025, [https://taylorandfrancis.com/knowledge/Medicine\_and\_healthcare/Medical\_ethics/Cognitive\_liberty/](https://taylorandfrancis.com/knowledge/Medicine_and_healthcare/Medical_ethics/Cognitive_liberty/)  
41. Cultivating cognitive liberty in the age of generative AI \- Microsoft Unlocked, accessed July 14, 2025, [https://unlocked.microsoft.com/ai-anthology/nita-farahany/](https://unlocked.microsoft.com/ai-anthology/nita-farahany/)  
42. I. Glenn Cohen \- Harvard Law School, accessed July 14, 2025, [https://hls.harvard.edu/faculty/i-glenn-cohen/](https://hls.harvard.edu/faculty/i-glenn-cohen/)  
43. The Project on Psychedelics Law and Regulation (POPLAR) \- Petrie-Flom Center, accessed July 14, 2025, [https://petrieflom.law.harvard.edu/the-project-on-psychedelics-law-and-regulation-poplar/](https://petrieflom.law.harvard.edu/the-project-on-psychedelics-law-and-regulation-poplar/)  
44. Harvard Professor I. Glenn Cohen on Psychedelics in Healthcare \- YouTube, accessed July 14, 2025, [https://www.youtube.com/watch?v=cPvr4j3rwac](https://www.youtube.com/watch?v=cPvr4j3rwac)  
45. Section 7 ‚Äì Life, liberty and security of the person \- Department of Justice Canada, accessed July 14, 2025, [https://www.justice.gc.ca/eng/csj-sjc/rfc-dlc/ccrf-ccdl/check/art7.html](https://www.justice.gc.ca/eng/csj-sjc/rfc-dlc/ccrf-ccdl/check/art7.html)  
46. R v Morgentaler Court case, accessed July 14, 2025, [https://en.wikipedia.org/wiki/R\_v\_Morgentaler\_(1993)](https://en.wikipedia.org/wiki/R_v_Morgentaler_\(1993\))  
47. R. v. Morgentaler | Gender Justice | US Law | LII / Legal Information ..., accessed July 14, 2025, [https://www.law.cornell.edu/gender-justice/resource/r\_v\_morgentaler](https://www.law.cornell.edu/gender-justice/resource/r_v_morgentaler)  
48. Regina v Parker (2000) 188 DLR (4th) 385 \- AustLII, accessed July 14, 2025, [http://classic.austlii.edu.au/au/journals/AUJlHRights/2001/19.pdf](http://classic.austlii.edu.au/au/journals/AUJlHRights/2001/19.pdf)  
49. Combating drug use while respecting Charter rights \- Human Rights Law Centre, accessed July 14, 2025, [https://www.hrlc.org.au/case-summaries/combating-drug-use-while-respecting-charter-rights/](https://www.hrlc.org.au/case-summaries/combating-drug-use-while-respecting-charter-rights/)  
50. Canada (Attorney General) v. PHS Community Services Society \- SCC Cases, accessed July 14, 2025, [https://decisions.scc-csc.ca/scc-csc/scc-csc/en/item/7960/index.do](https://decisions.scc-csc.ca/scc-csc/scc-csc/en/item/7960/index.do)  
51. Special Senate Committee on Illegal Drugs (37th Parliament, 1st Session), accessed July 14, 2025, [https://sencanada.ca/content/sen/committee/371/ille/library/drugs-e.htm](https://sencanada.ca/content/sen/committee/371/ille/library/drugs-e.htm)  
52. R v Malmo-Levine; R v Caine \- Wikipedia, accessed July 14, 2025, [https://en.wikipedia.org/wiki/R\_v\_Malmo-Levine;\_R\_v\_Caine](https://en.wikipedia.org/wiki/R_v_Malmo-Levine;_R_v_Caine)  
53. R. v. Malmo-Levine; R. v. Caine \- SCC Cases, accessed July 14, 2025, [https://decisions.scc-csc.ca/scc-csc/scc-csc/en/item/2109/index.do](https://decisions.scc-csc.ca/scc-csc/scc-csc/en/item/2109/index.do)  
54. R v. Malmo-Levine; R v. Caine \- Global Health & Human Rights Database |, accessed July 14, 2025, [https://www.globalhealthrights.org/r-v-malmo-levine-r-v-caine/](https://www.globalhealthrights.org/r-v-malmo-levine-r-v-caine/)  
55. Introduction | Open History Seminar: Canadian History, accessed July 14, 2025, [https://openhistoryseminar.com/canadianhistory/chapter/introduction-14/](https://openhistoryseminar.com/canadianhistory/chapter/introduction-14/)  
56. Canada's Boozy History | Cranbrook History Centre, accessed July 14, 2025, [https://www.cranbrookhistorycentre.com/canadas-boozy-history/](https://www.cranbrookhistorycentre.com/canadas-boozy-history/)  
57. Prohibition in Canada | The Canadian Encyclopedia, accessed July 14, 2025, [https://www.thecanadianencyclopedia.ca/en/article/prohibition](https://www.thecanadianencyclopedia.ca/en/article/prohibition)  
58. Controlled Drugs and Substances Act ( SC 1996, c. 19\) \- Laws.justice.gc.ca, accessed July 14, 2025, [https://laws-lois.justice.gc.ca/eng/acts/c-38.8/fulltext.html](https://laws-lois.justice.gc.ca/eng/acts/c-38.8/fulltext.html)  
59. The colourful history of LSD trials in Saskatchewan \- Sask Dispatch, accessed July 14, 2025, [https://saskdispatch.com/articles/view/the-colourful-history-of-LSD-trials-in-saskatchewan](https://saskdispatch.com/articles/view/the-colourful-history-of-LSD-trials-in-saskatchewan)  
60. Psychedelic Psychiatry: LSD On the Canadian Prairies \- Active History, accessed July 14, 2025, [https://activehistory.ca/blog/2014/03/12/psychedelic-psychiatry-lsd-on-the-canadian-prairies/](https://activehistory.ca/blog/2014/03/12/psychedelic-psychiatry-lsd-on-the-canadian-prairies/)  
61. "Just Say Know": Criminalizing LSD and the Politics of Psychedelic Expertise, 1961‚Äì8: Social, Legal, and Historical Perspectives on the Regulation of Drugs in Canada \- ResearchGate, accessed July 14, 2025, [https://www.researchgate.net/publication/319064047\_Just\_Say\_Know\_Criminalizing\_LSD\_and\_the\_Politics\_of\_Psychedelic\_Expertise\_1961-8\_Social\_Legal\_and\_Historical\_Perspectives\_on\_the\_Regulation\_of\_Drugs\_in\_Canada](https://www.researchgate.net/publication/319064047_Just_Say_Know_Criminalizing_LSD_and_the_Politics_of_Psychedelic_Expertise_1961-8_Social_Legal_and_Historical_Perspectives_on_the_Regulation_of_Drugs_in_Canada)  
62. LSD and The Hippies: A Focused Analysis of Criminalization and ..., accessed July 14, 2025, [https://pitjournal.unc.edu/2023/01/05/lsd-and-the-hippies-a-focused-analysis-of-criminalization-and-persecution-in-the-sixties/](https://pitjournal.unc.edu/2023/01/05/lsd-and-the-hippies-a-focused-analysis-of-criminalization-and-persecution-in-the-sixties/)  
63. View of Something in the Water: The American Acid Endemic \- Revue YOUR Review, accessed July 14, 2025, [https://yourreview.journals.yorku.ca/index.php/yourreview/article/view/40305/36498](https://yourreview.journals.yorku.ca/index.php/yourreview/article/view/40305/36498)  
64. Moral Panics and Disproportionality: The Case of LSD Use in the Sixties \- ResearchGate, accessed July 14, 2025, [https://www.researchgate.net/publication/248985866\_Moral\_Panics\_and\_Disproportionality\_The\_Case\_of\_LSD\_Use\_in\_the\_Sixties](https://www.researchgate.net/publication/248985866_Moral_Panics_and_Disproportionality_The_Case_of_LSD_Use_in_the_Sixties)  
65. Policy concerning the imposition of random drug testing: Employer's burden of proof, accessed July 14, 2025, [https://lorangermarcoux.com/en/knowledge/policy-concerning-the-imposition-of-random-drug-testing-employers-burden-of-proof](https://lorangermarcoux.com/en/knowledge/policy-concerning-the-imposition-of-random-drug-testing-employers-burden-of-proof)  
66. Safety-critical workers have ‚Äúdiminished expectation of privacy‚Äù in alcohol and drug testing, accessed July 14, 2025, [https://www.nortonrosefulbright.com/en/knowledge/publications/ac97f20d/safety-critical-workers-have-diminished-expectation-of-privacy-in-alcohol-and-drug-testing](https://www.nortonrosefulbright.com/en/knowledge/publications/ac97f20d/safety-critical-workers-have-diminished-expectation-of-privacy-in-alcohol-and-drug-testing)  
67. The Supreme Court of Canada Strikes Down Random ... \- Hicks Morley, accessed July 14, 2025, [https://hicksmorley.com/2013/06/19/the-supreme-court-of-canada-strikes-down-random-alcohol-testing-policy/](https://hicksmorley.com/2013/06/19/the-supreme-court-of-canada-strikes-down-random-alcohol-testing-policy/)  
68. Harm Reduction \- Alberta Health Services, accessed July 14, 2025, [https://www.albertahealthservices.ca/dsa/Page15432.aspx](https://www.albertahealthservices.ca/dsa/Page15432.aspx)  
69. Harm Reduction Principles, accessed July 14, 2025, [https://harmreduction.org/about-us/principles-of-harm-reduction/](https://harmreduction.org/about-us/principles-of-harm-reduction/)  
70. Why Portland failed where Portugal succeeded in decriminalizing ..., accessed July 14, 2025, [https://www.politico.eu/article/why-portland-failed-where-portugal-succeeded-in-decriminalizing-drugs/](https://www.politico.eu/article/why-portland-failed-where-portugal-succeeded-in-decriminalizing-drugs/)  
71. Drug Decriminalization in Portugal, accessed July 14, 2025, [https://drugpolicy.org/wp-content/uploads/2023/08/dpa-drug-decriminalization-portugal-health-human-centered-approach\_0.pdf](https://drugpolicy.org/wp-content/uploads/2023/08/dpa-drug-decriminalization-portugal-health-human-centered-approach_0.pdf)  
72. Drug decriminalisation in Portugal: setting the record straight., accessed July 14, 2025, [https://transformdrugs.org/blog/drug-decriminalisation-in-portugal-setting-the-record-straight](https://transformdrugs.org/blog/drug-decriminalisation-in-portugal-setting-the-record-straight)  
73. Drug Decriminalization Under Attack \- CATIE.ca, accessed July 14, 2025, [https://www.catie.ca/positive-side/drug-decriminalization-under-attack](https://www.catie.ca/positive-side/drug-decriminalization-under-attack)  
74. Special Senate Committee on Illegal Drugs (37th Parliament, 1st Session), accessed July 14, 2025, [https://sencanada.ca/senresolver/senatecontenthtmlfile?val=Committee/371/ille/library/dupras-e](https://sencanada.ca/senresolver/senatecontenthtmlfile?val=Committee/371/ille/library/dupras-e)  
75. Psychotropic Substances \- INCB, accessed July 14, 2025, [https://www.incb.org/incb/en/psychotropics/index.html](https://www.incb.org/incb/en/psychotropics/index.html)  
76. Conferences | Drugs \- Welcome to the United Nations, accessed July 14, 2025, [https://www.un.org/en/conferences/drug](https://www.un.org/en/conferences/drug)  
77. Committee Report No. 2 \- SNUD (37-2) \- House of Commons of Canada, accessed July 14, 2025, [https://www.ourcommons.ca/DocumentViewer/en/37-2/SNUD/report-2/page-261](https://www.ourcommons.ca/DocumentViewer/en/37-2/SNUD/report-2/page-261)  
78. Convention on Psychotropic Substances \- Wikipedia, accessed July 14, 2025, [https://en.wikipedia.org/wiki/Convention\_on\_Psychotropic\_Substances](https://en.wikipedia.org/wiki/Convention_on_Psychotropic_Substances)  
79. Should ayahuasca be made legal? A N.S. religious freedom case tests that argument, accessed July 14, 2025, [https://ca.news.yahoo.com/ayahuasca-made-legal-n-religious-223059205.html](https://ca.news.yahoo.com/ayahuasca-made-legal-n-religious-223059205.html)  
80. Legal status of ayahuasca by country \- Wikipedia, accessed July 14, 2025, [https://en.wikipedia.org/wiki/Legal\_status\_of\_ayahuasca\_by\_country](https://en.wikipedia.org/wiki/Legal_status_of_ayahuasca_by_country)